MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAVIN, T. N.
Right arrow Articles by LEFKOWITZ, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAVIN, T. N.
Right arrow Articles by LEFKOWITZ, R. J.

Molecular Pharmacology, Vol 20, 28-34, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Determination of Subtype Selectivity of Alpha-Adrenergic Antagonists

Comparison of Selective and Nonselective Radioligands

THOMAS N. LAVIN 1, BRIAN B. HOFFMAN 1, and ROBERT J. LEFKOWITZ 1

1 Howard Hughes Medical Institute, Departments of Medicine (Division of Cardiology) and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

The alpha1/alpha2-adrenergic receptor subtype selectivity of twelve adrenergic antagonists was assessed by two different radioligand binding approaches in rabbit uterine membranes which contain both receptor subtypes. In the first approach, a nonsubtype selective antagonist radioligand, [3H]dihydroergocryptine ([3H]DHE), was used to label all of the alpha-receptors. Selective competing ligands produced complex competition curves which could be analyzed by nonlinear least-squares curve-fitting methods to yield the Kd values of the competitor for the alpha1- and alpha2-receptors, respectively. The second approach utilized the radioligand antagonists [3H]prazosin and [3H]yohimbine. [3H]Prazosin was found to label alpha1-receptors, whereas [3H]yohimbine labeled alpha2-receptors. Competition experiments performed with subtype selective antagonists with these radioligands produced steep uniphasic competition curves in all cases. Dissociation constants of drugs for the [3H]prazosin and [3H]yohimbine sites correlated highly with the alpha1 and alpha2 components of the complex [3H]DHE competition curves, respectively. Good quantitative agreement between the two sets of data was obtained, indicating the validity of both approaches for the determination of receptor subtype affinities. Nonetheless, use of subtype selective radioligands offered several advantages. When the nonsubtype selective radioligand [3H]DHE was used in this system, 100-fold selectivity of a competitor was required in order to determine reliably alpha1 and alpha2 affinities. In contrast, use of the selective radioligands discriminated much smaller degrees of selectivity without the necessity for sophisticated computer analysis of the data.

Note:
ACKNOWLEDGMENTS We would like to thank Drs. Frank E. Harrel and Andre De Lean for their helpful suggestions and statistical advice.

Submitted on November 26, 1980
Accepted on February 2, 1981




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. H. Hord, D. D. Denson, B. Stowe, and R. M. Haygood
{{alpha}}-1 and {{alpha}}-2 Adrenergic Antagonists Relieve Thermal Hyperalgesia in Experimental Mononeuropathy from Chronic Constriction Injury
Anesth. Analg., June 1, 2001; 92(6): 1558 - 1562.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics